Medical University of South Carolina (MUSC)

news

Novel heart failure drug could halt disease progression

17 January 2024 | By Catherine Eckford (European Pharmaceutical Review)

Heart failure drug acoramidis could increase survival rates in transthyretin amyloid cardiomyopathy (ATTR-CM), Phase III study data suggests.

news

Dual cystic fibrosis modulator therapy shows efficacy in four-year study

16 March 2023 | By Catherine Eckford (European Pharmaceutical Review)

Cystic fibrosis patients can safely take a dual combination of cystic fibrosis modulator drugs for four years, a study has shown.

news

Could default eligibility improve clinical trial enrolment?

9 March 2023 | By Catherine Eckford (European Pharmaceutical Review)

The number of potential clinical trial participants increased from over 51,000 to 1.7 million after researchers applied a new approach to improve eligibility.

news

Using Th17 cells researchers make adoptive T-cell transfer therapy viable

11 November 2020 | By Hannah Balfour (European Pharmaceutical Review)

Adoptive T-cell transfer therapy has had limited use due to the time involved in CD8+ T cell expansion, using a different type of T cell researchers were able to shorten this timeline, making the therapy more accessible.

news

Pyridostigmine reverses paediatric complications of botulinum toxin therapy

30 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Physicians have reported the first paediatric use of pyridostigmine to reverse complications from botulinum toxin therapy...